Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Schizophrenia

  Free Subscription


Articles published in Am J Psychiatry

Retrieve available abstracts of 57 articles:
HTML format



Single Articles


    April 2022
  1. CHAND GB, Singhal P, Dwyer DB, Wen J, et al
    Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population.
    Am J Psychiatry. 2022 Apr 12:appiajp21070686. doi: 10.1176/appi.ajp.21070686.
    PubMed     Abstract available


  2. O'KEEFFE D, Kinsella A, Waddington JL, Clarke M, et al
    20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis.
    Am J Psychiatry. 2022;179:288-297.
    PubMed     Abstract available


  3. CHUNG DW, Geramita MA, Lewis DA
    Synaptic Variability and Cortical Gamma Oscillation Power in Schizophrenia.
    Am J Psychiatry. 2022;179:277-287.
    PubMed     Abstract available


  4. KALIN NH
    Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia.
    Am J Psychiatry. 2022;179:255-258.
    PubMed    


  5. MALLA A
    Reducing Duration of Untreated Psychosis: The Neglected Dimension of Early Intervention Services.
    Am J Psychiatry. 2022;179:259-261.
    PubMed    


  6. SOHAL VS
    Transforming Discoveries About Cortical Microcircuits and Gamma Oscillations Into New Treatments for Cognitive Deficits in Schizophrenia.
    Am J Psychiatry. 2022;179:267-276.
    PubMed     Abstract available


    March 2022
  7. MANCINI V, Rochas V, Seeber M, Roehri N, et al
    Aberrant Developmental Patterns of Gamma-Band Response and Long-Range Communication Disruption in Youths With 22q11.2 Deletion Syndrome.
    Am J Psychiatry. 2022;179:204-215.
    PubMed     Abstract available


    January 2022
  8. GANESH S, D'Souza DC
    Cannabis and Psychosis: Recent Epidemiological Findings Continuing the "Causality Debate".
    Am J Psychiatry. 2022;179:8-10.
    PubMed    


  9. SANCHEZ-RICO M, Limosin F, Hoertel N
    Is a Diagnosis of Schizophrenia Spectrum Disorder Associated With Increased Mortality in Patients With COVID-19?
    Am J Psychiatry. 2022;179:71-73.
    PubMed    


    October 2021
  10. KALIN NH
    Depression and Schizophrenia: Sleep, Medical Risk Factors, Biomarkers, and Treatment.
    Am J Psychiatry. 2021;178:881-884.
    PubMed    


  11. CANNON TD
    Do the Benefits of Early Intervention Services for Psychosis Generalize and Persist in the Real World?
    Am J Psychiatry. 2021;178:890-892.
    PubMed    


    September 2021
  12. KALIN NH
    Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities.
    Am J Psychiatry. 2021;178:779-782.
    PubMed    


    August 2021
  13. PARKER DA, Trotti RL, McDowell JE, Keedy SK, et al
    Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features.
    Am J Psychiatry. 2021 Aug 19:appiajp202120071043.
    PubMed     Abstract available


    July 2021
  14. POSSELT CM, Albert N, Nordentoft M, Hjorthoj C, et al
    The Danish OPUS Early Intervention Services for First-Episode Psychosis: A Phase 4 Prospective Cohort Study With Comparison of Randomized Trial and Real-World Data.
    Am J Psychiatry. 2021 Jul 28:appiajp202120111596.
    PubMed     Abstract available


  15. WEISER M, Davis JM, Brown CH, Slade EP, et al
    Differences in Antipsychotic Treatment Discontinuation Among Veterans With Schizophrenia in the U.S. Department of Veterans Affairs.
    Am J Psychiatry. 2021 Jul 14:appiajp202020111657.
    PubMed     Abstract available


  16. MARDER SR
    Changing the Face of Schizophrenia.
    Am J Psychiatry. 2021;178:584-585.
    PubMed    


    May 2021
  17. JOSHI YB, Thomas ML, Braff DL, Green MF, et al
    Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Am J Psychiatry. 2021 May 14:appiajp202020081212.
    PubMed     Abstract available


  18. ANGLIN DM, Ereshefsky S, Klaunig MJ, Bridgwater MA, et al
    From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the United States.
    Am J Psychiatry. 2021 May 3:appiajp202020071091.
    PubMed     Abstract available


  19. HONER WG
    Better Evidence for Pharmacological Maintenance Treatment in Nonaffective Psychoses: Implications for Relapse Prevention.
    Am J Psychiatry. 2021;178:369-371.
    PubMed    


  20. FERRARELLI F, Phillips ML
    Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments.
    Am J Psychiatry. 2021;178:400-413.
    PubMed     Abstract available


    April 2021
  21. AMSALEM D, Markowitz JC, Jankowski SE, Yang LH, et al
    Sustained Effect of a Brief Video in Reducing Public Stigma Toward Individuals With Psychosis: A Randomized Controlled Trial of Young Adults.
    Am J Psychiatry. 2021 Apr 26:appiajp202020091293.
    PubMed     Abstract available


    March 2021
  22. FERRARELLI F
    Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps.
    Am J Psychiatry. 2021 Mar 17:appiajp202020070968.
    PubMed     Abstract available


  23. FAAY MDM, Sommer IE
    Risk and Prevention of Aggression in Patients With Psychotic Disorders.
    Am J Psychiatry. 2021;178:218-220.
    PubMed    


    February 2021
  24. OSTUZZI G, Bertolini F, Del Giovane C, Tedeschi F, et al
    Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
    Am J Psychiatry. 2021 Feb 18:appiajp202020071120.
    PubMed     Abstract available


    January 2021
  25. KRAKOWSKI M, Tural U, Czobor P
    The Importance of Conduct Disorder in the Treatment of Violence in Schizophrenia: Efficacy of Clozapine Compared With Olanzapine and Haloperidol.
    Am J Psychiatry. 2021 Jan 21:appiajp202020010052.
    PubMed     Abstract available


  26. KRAGULJAC NV, McDonald WM, Widge AS, Rodriguez CI, et al
    Neuroimaging Biomarkers in Schizophrenia.
    Am J Psychiatry. 2021 Jan 5:appiajp202020030340.
    PubMed     Abstract available


    December 2020
  27. KALIN NH
    Molecules and Circuits Implicated in Schizophrenia Provide Leads for Novel Treatments.
    Am J Psychiatry. 2020;177:1099-1102.
    PubMed    


  28. IYER SN, Anderson KK, Malla A, Shah J, et al
    The Case for Cautious Interpretation and Replication: Lead-Time Bias as a Potential Explanation for the Link Between Duration of Untreated Psychosis and Outcome.
    Am J Psychiatry. 2020;177:1180-1181.
    PubMed    


  29. DWIVEDI Y
    Cell-Type-Specific Transcriptomic Analysis in the Dorsolateral Prefrontal Cortex Reveals Distinct Mitochondrial Abnormalities in Schizophrenia and Bipolar Disorder.
    Am J Psychiatry. 2020;177:1107-1109.
    PubMed    


  30. JONAS KG, Fochtmann LJ, Perlman G, Tian Y, et al
    Lead-Time Bias as a Potential Explanation for the Link Between Duration of Untreated Psychosis and Outcome: Response to Iyer et al.
    Am J Psychiatry. 2020;177:1181-1183.
    PubMed    


  31. WOODS SW, Yung AR, McGorry PD, McGlashan TH, et al
    Duration of Untreated Psychosis: Getting Both the Timing and the Sample Right.
    Am J Psychiatry. 2020;177:1183.
    PubMed    


  32. JONAS KG, Fochtmann LJ, Perlman G, Tian Y, et al
    Duration of Untreated Psychosis: Getting Both the Timing and the Sample Right: Response to Woods et al.
    Am J Psychiatry. 2020;177:1183-1185.
    PubMed    


  33. COYLE JT, Ruzicka WB, Balu DT
    Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse.
    Am J Psychiatry. 2020;177:1119-1128.
    PubMed    


  34. BUCHANAN RW
    How Much of an Advance Is the Addition of Samidorphan to Olanzapine?
    Am J Psychiatry. 2020;177:1113-1114.
    PubMed    


  35. SRIHARI VH, Guloksuz S, Friis S
    Natural History, Not Lead Time.
    Am J Psychiatry. 2020;177:1185.
    PubMed    


  36. JONAS KG, Fochtmann LJ, Perlman G, Tian Y, et al
    Natural History, Not Lead Time: Response to Srihari et al.
    Am J Psychiatry. 2020;177:1185-1186.
    PubMed    


  37. FRISTON KJ
    Bayesian Dysconnections.
    Am J Psychiatry. 2020;177:1110-1112.
    PubMed    


    October 2020
  38. GLAUSIER JR, Enwright JF 3rd, Lewis DA
    Diagnosis- and Cell Type-Specific Mitochondrial Functional Pathway Signatures in Schizophrenia and Bipolar Disorder.
    Am J Psychiatry. 2020 Oct 29:appiajp202019111210.
    PubMed     Abstract available


    September 2020
  39. HUANG AS, Rogers BP, Sheffield JM, Jalbrzikowski ME, et al
    Thalamic Nuclei Volumes in Psychotic Disorders and in Youths With Psychosis Spectrum Symptoms.
    Am J Psychiatry. 2020 Sep 11:appiajp202019101099.
    PubMed     Abstract available


  40. KEEPERS GA, Fochtmann LJ, Anzia JM, Benjamin S, et al
    The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.
    Am J Psychiatry. 2020;177:868-872.
    PubMed    


  41. POST RM
    Early Detection and Preventive Treatment in Bipolar Disorder.
    Am J Psychiatry. 2020;177:867.
    PubMed    


    August 2020
  42. CORRELL CU, Newcomer JW, Silverman B, DiPetrillo L, et al
    Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study.
    Am J Psychiatry. 2020 Aug 14:appiajp202019121279.
    PubMed     Abstract available


    July 2020
  43. MUSLINER KL, Krebs MD, Albinana C, Vilhjalmsson B, et al
    Polygenic Risk and Progression to Bipolar or Psychotic Disorders Among Individuals Diagnosed With Unipolar Depression in Early Life.
    Am J Psychiatry. 2020 Jul 14:appiajp202019111195.
    PubMed     Abstract available


  44. DUGRE JR, Dumais A, Potvin S
    Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: Response to Rasetti et al.
    Am J Psychiatry. 2020;177:640-641.
    PubMed    


  45. RASETTI R, Chen Q, Weinberger DR
    Comment on Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: A Neuroimaging Meta-Analysis of the Hypervigilant Mind.
    Am J Psychiatry. 2020;177:639-640.
    PubMed    


  46. EISENBERG DP, Gregory MD, Berman KF
    Subcortical Signatures of Hemizygosity and Psychosis in 22q11.2 Deletion Syndrome: Finding Common Ground in Rare Genetic Variation.
    Am J Psychiatry. 2020;177:564-566.
    PubMed    


    June 2020
  47. HARVEY PD
    An Array of Studies Addressing Cognition and Cognitively Defined Neuropsychiatric Conditions: Many More Connections Than You Might Think.
    Am J Psychiatry. 2020;177:491-496.
    PubMed     Abstract available


    May 2020
  48. GREENMAN DLB, La MAN, Shah S, Chen Q, et al
    Parietal-Prefrontal Feedforward Connectivity in Association With Schizophrenia Genetic Risk and Delusions.
    Am J Psychiatry. 2020 May 27:appiajp202019111176.
    PubMed     Abstract available


    April 2020
  49. ZANELLI J, Mollon J, Sandin S, Reichenberg A, et al
    Are Visual Memory Deficits in Recent-Onset Psychosis Degenerative? Response to Smucny et al.
    Am J Psychiatry. 2020;177:356-357.
    PubMed    


  50. PANAYIOTOU A, Wood S, Stainton A, Van Rheenen T, et al
    Failing to Gain: Another Explanation of Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode.
    Am J Psychiatry. 2020;177:354.
    PubMed    


  51. ZANELLI J, Mollon J, Sandin S, Reichenberg A, et al
    Further Analysis of Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode: Response to Panayiotou et al.
    Am J Psychiatry. 2020;177:354-355.
    PubMed    


  52. SMUCNY J, Zarubin VC, Ragland JD, Carter CS, et al
    Are Visual Memory Deficits in Recent-Onset Psychosis Degenerative?
    Am J Psychiatry. 2020;177:355-356.
    PubMed    


  53. KAHN RS
    On the Origins of Schizophrenia.
    Am J Psychiatry. 2020;177:291-297.
    PubMed    


  54. LEWANDOWSKI KE
    Genetically, Developmentally, and Clinically Distinct Cognitive Subtypes in Schizophrenia: A Tale of Three Trajectories.
    Am J Psychiatry. 2020;177:282-284.
    PubMed    


  55. KALIN NH
    Psychotic Experiences, Cognitive Decline, and Genetic Vulnerabilities in Relation to Developing Psychotic Disorders.
    Am J Psychiatry. 2020;177:279-281.
    PubMed    


    March 2020
  56. HOLLERAN L, Kelly S, Alloza C, Agartz I, et al
    The Relationship Between White Matter Microstructure and General Cognitive Ability in Patients With Schizophrenia and Healthy Participants in the ENIGMA Consortium.
    Am J Psychiatry. 2020 Mar 26:appiajp201919030225.
    PubMed     Abstract available


    January 2020
  57. KALIN NH, Binder E, Brady KT, Lewis DA, et al
    2019 Articles of Import and Impact.
    Am J Psychiatry. 2020;177:17-19.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: